P Briand
- Co-authors
- A. E. LykkesfeldtMogens Winkel MadsenInga LaursenAnne E. LykkesfeldtH.T. MouridsenIb Jarle ChristensenKeld DanøM Blichert-Toft
- Topics
- Estrogen and related hormone effects (6 papers)Protease and Inhibitor Mechanisms (3 papers)Peptidase Inhibition and Analysis (2 papers)
- Cited by
- GeneticsOncologyCancer Research
- Journals
- FEBS LettersTumor BiologyPubMed
In The Last Decade
P Briand
13 papers receiving 458 citations
Peers
Comparison fields: 5 of 68
- Genetics 229
- Oncology 218
- Molecular Biology 195
- Cancer Research 107
- Pulmonary and Respiratory Medicine 35
Countries citing papers authored by P Briand
This map shows the geographic impact of P Briand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Briand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Briand more than expected).
Fields of papers citing papers by P Briand
This network shows the impact of papers produced by P Briand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Briand. The network helps show where P Briand may publish in the future.
Co-authorship network of co-authors of P Briand
This figure shows the co-authorship network connecting the top 25 collaborators of P Briand. A scholar is included among the top collaborators of P Briand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Briand. P Briand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | The complex between urokinase and its type-1 inhibitor in primary breast cancer: relation to survival. | 31 |
| 2 | Estrogen receptor messenger RNA splice variants are not involved in antiestrogen resistance in sublines of MCF-7 human breast cancer cells. | 50 |
| 3 | Plasminogen activator inhibitor type 1 in cytosolic tumor extracts predicts prognosis in low-risk breast cancer patients. | 38 |
| 4 | 33 | |
| 5 | Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1. | 139 |
| 6 | Serum albumin as a modulator on growth of the human breast cancer cell line, MCF-7. | 93 |
| 7 | 2 | |
| 8 | Estrogen-dependent release of serum proteins from MCF-7 breast carcinoma cells in vitro. | 10 |
| 9 | Long-term cultivation of a human breast cancer cell line, MCF-7, in a chemically defined medium. Effect of estradiol. | 36 |
| 10 | Hormone-dependent mammary tumors in mice and rats as a model for human breast cancer (review). | 38 |
| 11 | 1 | |
| 12 | Intra-arterial combined cancer chemotherapy in technically inoperable carcinoma of the anus and rectum. | 4 |
| 13 | The activity of phosphofructokinase and lactate dehydrogenase in cancer of the colon and rectum and the effect of iodine on the normal mucosa. | 2 |
About P Briand
P Briand is a scholar working on Cancer Research, Genetics and Immunology and Allergy, having authored 13 papers that have together received 477 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (6 papers), Protease and Inhibitor Mechanisms (3 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Genetics (229 citations), Oncology (218 citations) and Cancer Research (107 citations). P Briand has collaborated with scholars based in Denmark and Germany. Frequent co-authors include A. E. Lykkesfeldt, Mogens Winkel Madsen, Inga Laursen, Anne E. Lykkesfeldt, H.T. Mouridsen, Ib Jarle Christensen, Keld Danø, M Blichert-Toft, J Grøndahl-Hansen and Jens Krøll. Their work appears in journals such as FEBS Letters, Tumor Biology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.